Conjugated linoleic acid

319produits homologués
1 monographie
Capsule, soft, Capsule, Powder +2

Monographies de Santé Canada

1

Allégations santé approuvées

6
  • May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity
  • May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity
  • If a body composition/reduction of fat mass claim is made:
  • Improvement of body composition/reduction of fat mass is a long-term process and must therefore be associated with a long-term intervention
  • Medicinal ingredient with diuretic properties may be included in products associated with weight management, however no diuretic claim can be applied as it is associated with a short-term duration of use (occasional use only)
  • Stimulant laxatives cannot be present at therapeutic dose in products associated with weight management as their short term duration of use is not compatible with the duration of use for weight management

Plages de doses approuvées

3
PopulationPlage de dosesFréquence
Adults 18 years and older3–5 gramsper day
Adults 18 years and older4–6.5 g
Adults 18 years and older3–5 g

Mises en garde et contre-indications

6
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.
contraindicationDo not use if you are pregnant (HC 2010).
contraindicationDo not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).
adverse_reactionWhen using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).

Noms alternatifs

3
CLA(common)Conjugated linoleic acid(common)Conjugated linoleic acid

Quantités courantes dans les produits homologués

10
1000 mg70 produits homologués
1000 milligrams37 produits homologués
800 mg32 produits homologués
500 mg23 produits homologués
800 milligrams18 produits homologués
1 g16 produits homologués
260 mg14 produits homologués
250 mg12 produits homologués
780 milligrams11 produits homologués
125 mg9 produits homologués

Vérifiez la conformité de votre produit contenant Conjugated linoleic acid

Validez votre formulation contre les monographies de Santé Canada et 319 produits homologués contenant Conjugated linoleic acid.

Analyser gratuitement